MSD’s sotatercept has become the first FDA-approved therapy for pulmonary arterial hypertension (PAH) that addresses the underlying mechanism behind the disease, rather than its symptoms.
When Emily Jansson boarded her flight from Toronto to Dubai on Feb. 5, she had no idea her girls’ trip would take a dangerous turn. The 33-year-old wife and mother-of-two got up to go to the bathroom ...
Clinicians discuss the rapidly evolving therapies, technology, and surgical approaches for early-stage NSCLC and take a fresh look at the future of care. Teamwork: A Multidisciplinary Approach to ...
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...
Copyright: © 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies. The 2023 ESH guidelines ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback